Zahradnik Lab
Tamura T, Mizuma K, Nasser H, Deguchi S, Padilla-Blanco M, Oda Y, Uriu K, Tolentino JEM, Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Wang L, Tsuda M, Jonathan M, Kosugi Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ito J, Irie T, Tanaka S, Zahradnik J, Ikeda T, Takayama K, Matsuno K, Fukuhara T, Sato K. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell Host Microbe. 2024 Feb 14;32(2):170-180.e12. doi: 10.1016/j.chom.2024.01.001. (IF 30.3)
Tamura, T., Mizuma, K., Nasser, H., Deguchi, S, Padilla-Blanco M. (co-first author), + 25 authors, Tanaka, S., Zahradnik, J. (corresponding), Ikeda, T., Takayama, K., Matsuno, K., Fukuhara, T., Sato, K. (2023) Virological characteristics of the SARS-CoV-2 BA.2.86 variant, Cell Host Microbe, accepted Dec 21, CELL-HOST-MICROBE-D-23-01126R1. (IF 30.3)
Kaku, Y., Okumura, K., Padilla-Blanco, M. (co-first author), Kosugi, Y., Uriu, K., Hinay, A., Chen, L., Plianchaisuk, A., Kobiyama, K., Ishii, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, Zahradnik, J. (corresponding), Ito, J., Sato, K. (2023) Virological characteristics of the SARS-CoV-2 JN.1 variant, Lancet Inf. Dis., accepted Dec 15, THELANCETID-D-23-01732R1. (IF 56.3)
Kimura I, Yamasoba D, Nasser H, Ito H, Zahradnik J, Wu J, Fujita S, Uriu K, Sasaki J, Tamura T, Suzuki R, Deguchi S, Plianchaisuk A, Yoshimatsu K, Kazuma Y, Mitoma S, Schreiber G, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Shirakawa K, Takayama K, Irie T, Hashiguchi T, Nakagawa S, Fukuhara T, Saito A, Ikeda T, Sato K. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics. J Virol. 2023 Oct 31;97(10):e0101123. doi: 10.1128/jvi.01011-23. (IF 5.4) [PubMed]
Pham PN, Zahradník J, Kolářová L, Schneider B, Fuertes G. Regulation of IL-24/IL-20R2 complex formation using photocaged tyrosines and UV light. Front Mol Biosci. 2023 Jul 7;10:1214235. doi: 10.3389/fmolb.2023.1214235. (IF 5.0) [PubMed]
Masuda Y, Nasser H, Zahradnik J, Mitoma S, Shimizu R, Nagata K, Takaori-Kondo A, Schreiber G, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Shirakawa K, Saito A, Ikeda T, Ito J and Sato K (2023) Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein. Front. Virol. 3:1328229. doi: 10.3389/fviro.2023.1328229. (IF N/A)
Yamasoba D, Uriu K, Plianchaisuk A, Kosugi Y, Pan L, Zahradnik J; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant. Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3. (IF 56.3) [PubMed]
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 2023 May 16;14(1):2800. doi: 10.1038/s41467-023-38435-3. (IF 16.6) [PubMed]
Ito J, Suzuki R, Uriu K, Itakura Y, Zahradnik J, Kimura KT, Deguchi S, Wang L, Lytras S, Tamura T, Kida I, Nasser H, Shofa M, Begum MM, Tsuda M, Oda Y, Suzuki T, Sasaki J, Sasaki-Tabata K, Fujita S, Yoshimatsu K, Ito H, Nao N, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Kuramochi J, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Matsuno K, Takayama K, Hashiguchi T, Tanaka S, Fukuhara T, Ikeda T, Sato K. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nat Commun. 2023 May 11;14(1):2671. doi: 10.1038/s41467-023-38188-z. (IF 16.6) [PubMed]
Uriu K, Ito J, Zahradnik J, Fujita S, Kosugi Y, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant. Lancet Infect Dis. 2023 Mar;23(3):280-281. doi: 10.1016/S1473-3099(23)00051-8. (IF 56.3) [PubMed]
Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y, Kimura I, Ito J, Yamasoba D, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Shofa M, Monira Begum M, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe. 2022 Nov 9;30(11):1540-1555.e15. doi: 10.1016/j.chom.2022.10.003. (IF 31.37) [PubMed]